Agilon 上调 2026 年展望至 58 亿美元营收及 8500 万美元经调整 EBITDA，风险调整预估增至 3% (NYSE:AGL)
· seekingalpha.com
agilon health (AGL) 2026 年第二季度财报电话会议回顾：上调全年指引、改善成本趋势、风险调整及 AI 优先事项。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...